Overview

A Study to Evaluate Efficacy and Safety of VX-150 in Subjects With Acute Pain Following Bunionectomy

Status:
Completed
Trial end date:
2017-12-08
Target enrollment:
Participant gender:
Summary
This is a Phase 2 randomized, double-blind, placebo-controlled, 3-arm, parallel design study to evaluate the efficacy and safety of VX-150 in treating acute pain following bunionectomy.
Phase:
Phase 2
Details
Lead Sponsor:
Vertex Pharmaceuticals Incorporated